Prospective Cohort Study of Rapid Response Team

NCT ID: NCT02986581

Last Updated: 2021-06-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

79800 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-11-30

Study Completion Date

2026-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to collect data of rapid response team activated patients prospectively

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

acutely deteriorating patients including sudden cardiac arrest in general ward who are monitored and intervened by rapid response team

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hospital Medical Emergency Team Medicine, Emergency Hospital Rapid Response Team

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Patients admitted to general ward in Seoul National University Bundang Hospital and monitored by in-hospital rapid response system.

Exclusion Criteria

* patients admitted to pediatric wards
* patients in emergency room, intensive care unit, and operating room
Minimum Eligible Age

15 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Seoul National University Bundang Hospital

OTHER

Sponsor Role collaborator

Seoul National University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yeon Joo Lee, MD

Role: PRINCIPAL_INVESTIGATOR

Seoul National University Bundang Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Seoul National University Bundang Hospital

Seongnam-si, , South Korea

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yeon Joo Lee, MD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yeon Joo Lee, MD

Role: primary

+82317877082

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SAFER_20161101

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Swiss Trauma Registry
NCT03526029 RECRUITING